Aligos Therapeutics Inc (ALGS)
0.784
0.00 (0.00%)
USD |
NASDAQ |
Apr 18, 16:00
0.7853
0.00 (0.00%)
After-Hours: 20:00
Aligos Therapeutics Cash and Short Term Investments (Quarterly): 135.70M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 135.70M |
| September 30, 2023 | 70.43M |
| June 30, 2023 | 90.84M |
| March 31, 2023 | 103.52M |
| December 31, 2022 | 125.83M |
| September 30, 2022 | 142.30M |
| June 30, 2022 | 159.34M |
| March 31, 2022 | 183.22M |
| Date | Value |
|---|---|
| December 31, 2021 | 190.73M |
| September 30, 2021 | 242.18M |
| June 30, 2021 | 190.65M |
| March 31, 2021 | 213.42M |
| December 31, 2020 | 243.51M |
| September 30, 2020 | 70.06M |
| June 30, 2020 | 128.90M |
| December 31, 2019 | 117.66M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
70.06M
Minimum
Sep 2020
243.51M
Maximum
Dec 2020
150.52M
Average
139.00M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Mirum Pharmaceuticals Inc | 286.33M |
| CEL-SCI Corp | 3.241M |
| AIM ImmunoTech Inc | 13.07M |
| IGC Pharma Inc | 1.378M |
| NovaBay Pharmaceuticals Inc | 3.13M |